Merck, a leading science and technology company, today announced that Health Canada has approved MAVENCLAD™ (Cladribine Tablets) as monotherapy for...
Dance Biopharm Holdings Inc. ("Dance"), a privately-held biotechnology company focused on the development of Dance 501, a proprietary 'soft-mist' inhaled...
AgriLabs® today announced that it has developed a set of master seeds for a replication-deficient human adenovirus vector that expresses...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has completed the acquisition of certain assets...
Personalized medicine is taking new and powerful forms in the field of immunotherapy. The technology behind making customized tumor-destroying cells,...
The letter of intent signed to develop this oil & gas company's large acreage in the red-hot Permian Basin would...
Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel therapeutics for the treatment of cancer, and Catalent, the...
The European Medicines Agency (EMA) has accepted to review Mylan’s marketing authorisation applications (MAA) for proposed biosimilar trastuzumab and proposed...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases,...
Grifols , a leading global producer of plasma-derived medicines and provider of sterile compounding-related technologies and services for hospitals, clinics,...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
